Target intelligence / Profile preview

Transient receptor potential vanilloid 1 and Transient receptor potential ankyrin 1 (TRPV1 and TRPA1)

Target
TRPV1 and TRPA1
Molecular classification
Ion channel, Transient receptor potential (TRP) channel family, Receptor
01

Overview

Transient receptor potential vanilloid 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1) are non-selective cation channels that function as critical polymodal sensors in the peripheral nervous system. They are predominantly co-expressed in nociceptive sensory neurons, where they integrate a variety of noxious stimuli including extreme temperatures, acidic pH, and chemical irritants like capsaicin (TRPV1) and mustard oil (TRPA1). Their activation triggers the influx of calcium and sodium, leading to action potential generation and the release of pro-inflammatory neuropeptides such as substance P and CGRP, which drive neurogenic inflammation. Beyond their role in acute and chronic pain, these channels are involved in the pathophysiology of respiratory diseases like asthma and chronic cough, as well as gastrointestinal and dermatological conditions. While they are distinct proteins, their functional interlinking has led to the development of dual antagonists aimed at providing superior analgesic efficacy compared to single-target inhibitors. However, clinical progress has been complicated by side effects such as hyperthermia and impaired thermal sensitivity, particularly associated with TRPV1 modulation.

Other names
Capsaicin receptorVanilloid receptor 1VR1Mustard oil receptorAnkyrin-like protein 1ANKTM1TRPV1/TRPA1 functional complex
02

Mechanism of action

Antagonism of cation influx to prevent neuronal firing; Agonism followed by prolonged channel desensitization to deplete neuropeptides.

03

Biological functions

Signal transductionNociceptionThermoregulationNeurogenic inflammationChemosensationVasodilationItch sensation
04

Disease associations

InflammationChronic painNeuropathic painAsthmaChronic coughInflammatory bowel diseasePruritusObesityDiabetes
05

Safety considerations

Hyperthermia (specifically with TRPV1 antagonists)Impaired noxious heat sensation and risk of scalding burnsCardiovascular safety signals (heart rate and blood pressure changes)Alteration of respiratory reflex arcs
06

Interacting drugs

Capsaicin

7 more in the full profile.

07

Biomarkers

Substance P levelsCalcitonin gene-related peptide (CGRP) levelsIntracellular calcium influxHeat and cold pain thresholds

Beyond the preview

Go deeper on Transient receptor potential vanilloid 1 and Transient receptor potential ankyrin 1 (TRPV1 and TRPA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential vanilloid 1 and Transient receptor potential ankyrin 1 (TRPV1 and TRPA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call